EBS Stock-Based Compensation
Emergent Biosolutions Inc · Stock-Based Compensation
EBS Stock-Based Compensation
Latest reported$18.90Mperiod ending
EBS TTM Stock-Based Comp ($3.07M → $18.90M)
TTM stock-based compensation
High-resolution chart · PNG
EBS stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 18,900,000 | |
| 16,600,000 | |
| 16,200,000 | |
| 15,200,000 | |
| 12,700,000 | |
| 13,600,000 | |
| 18,000,000 | |
| 17,700,000 | |
| 19,400,000 | |
| 22,200,000 | |
| 23,100,000 | |
| 30,800,000 | |
| 38,000,000 | |
| 42,000,000 | |
| 45,100,000 | |
| 43,500,000 | |
| 42,700,000 | |
| 41,800,000 | |
| 42,400,000 | |
| 42,300,000 | |
| 41,900,000 | |
| 54,900,000 | |
| 51,000,000 | |
| 46,700,000 | |
| 42,800,000 | |
| 26,500,000 | |
| 26,700,000 | |
| 27,536,000 | |
| 26,436,000 | |
| 22,736,000 | |
| 23,236,000 | |
| 20,108,000 | |
| 18,895,000 | |
| 18,229,000 | |
| 15,213,000 | |
| 15,755,000 | |
| 16,550,000 | |
| 17,564,000 | |
| 18,477,000 | |
| 18,573,000 | |
| 18,003,000 | |
| 17,247,000 | |
| 15,848,000 | |
| 15,177,000 | |
| 14,604,000 | |
| 13,977,000 | |
| 12,829,000 | |
| 12,233,000 | |
| 11,535,000 | |
| 10,912,000 | |
| 11,238,000 | |
| 11,157,000 | |
| 11,408,000 | |
| 11,379,000 | |
| 11,115,000 | |
| 11,245,000 | |
| 11,014,000 | |
| 11,010,000 | |
| 10,739,000 | |
| 9,768,000 | |
| 8,850,000 | |
| 7,982,000 | |
| 7,063,000 | |
| 6,568,000 | |
| 6,120,000 | |
| 5,669,000 | |
| 5,007,000 | |
| 6,155,000 | |
| 4,760,000 | |
| 4,126,000 | |
| 3,496,000 | |
| 3,527,000 | |
| 3,527,000 | |
| 2,771,000 | |
| 3,070,000 | |
| 1,252,000 |